PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 106 filers reported holding PMV PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.78 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $115,628 | -0.4% | 18,832 | +1.6% | 0.00% | – |
| Q2 2023 | $116,054 | -25.9% | 18,539 | -43.6% | 0.00% | – |
| Q1 2023 | $156,713 | -10.2% | 32,854 | +63.9% | 0.00% | – |
| Q4 2022 | $174,418 | -2.0% | 20,048 | +34.1% | 0.00% | – |
| Q3 2022 | $178,000 | -28.2% | 14,946 | -14.2% | 0.00% | – |
| Q2 2022 | $248,000 | -23.2% | 17,413 | +12.2% | 0.00% | – |
| Q1 2022 | $323,000 | -76.8% | 15,515 | -74.2% | 0.00% | -100.0% |
| Q4 2021 | $1,391,000 | -21.2% | 60,210 | +1.6% | 0.00% | 0.0% |
| Q3 2021 | $1,766,000 | -13.4% | 59,246 | -0.8% | 0.00% | 0.0% |
| Q2 2021 | $2,040,000 | +18.5% | 59,730 | +14.1% | 0.00% | 0.0% |
| Q1 2021 | $1,721,000 | -30.6% | 52,332 | +29.9% | 0.00% | -50.0% |
| Q4 2020 | $2,479,000 | – | 40,296 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERWEST VENTURE MANAGEMENT CO | 1,614,911 | $23,012,000 | 42.78% |
| Euclidean Capital LLC | 2,336,909 | $33,301,000 | 28.32% |
| OUP Management Co., LLC | 989,232 | $14,097,000 | 19.40% |
| Nextech Invest Ltd. | 1,385,807 | $19,748,000 | 6.66% |
| Boxer Capital, LLC | 3,498,636 | $49,856,000 | 3.16% |
| PERSONAL CFO SOLUTIONS, LLC | 550,342 | $7,842,000 | 1.84% |
| Orbimed Advisors | 6,563,077 | $93,524,000 | 1.70% |
| RTW INVESTMENTS, LP | 4,395,677 | $62,638,000 | 1.62% |
| ACUTA CAPITAL PARTNERS, LLC | 152,500 | $2,173,000 | 1.21% |
| Avoro Capital Advisors LLC | 3,100,000 | $44,175,000 | 0.87% |